These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 17703217

  • 1. Assessing the delivery efficacy and internalization route of cell-penetrating peptides.
    El Andaloussi S, Guterstam P, Langel U.
    Nat Protoc; 2007; 2(8):2043-7. PubMed ID: 17703217
    [Abstract] [Full Text] [Related]

  • 2. Induction of splice correction by cell-penetrating peptide nucleic acids.
    El-Andaloussi S, Johansson HJ, Lundberg P, Langel U.
    J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
    [Abstract] [Full Text] [Related]

  • 3. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
    Abes S, Moulton HM, Clair P, Prevot P, Youngblood DS, Wu RP, Iversen PL, Lebleu B.
    J Control Release; 2006 Dec 01; 116(3):304-13. PubMed ID: 17097177
    [Abstract] [Full Text] [Related]

  • 4. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides.
    Hassane FS, Abes R, El Andaloussi S, Lehto T, Sillard R, Langel U, Lebleu B.
    J Control Release; 2011 Jul 30; 153(2):163-72. PubMed ID: 21536086
    [Abstract] [Full Text] [Related]

  • 5. Distinct uptake routes of cell-penetrating peptide conjugates.
    Lundin P, Johansson H, Guterstam P, Holm T, Hansen M, Langel U, EL Andaloussi S.
    Bioconjug Chem; 2008 Dec 30; 19(12):2535-42. PubMed ID: 19012426
    [Abstract] [Full Text] [Related]

  • 6. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
    Guterstam P, Andaloussi SE, Langel U.
    Methods Mol Biol; 2011 Dec 30; 683():219-30. PubMed ID: 21053133
    [Abstract] [Full Text] [Related]

  • 7. Cell-penetrating peptides: mechanism and kinetics of cargo delivery.
    Zorko M, Langel U.
    Adv Drug Deliv Rev; 2005 Feb 28; 57(4):529-45. PubMed ID: 15722162
    [Abstract] [Full Text] [Related]

  • 8. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
    Shiraishi T, Nielsen PE.
    Methods Mol Biol; 2011 Feb 28; 683():391-7. PubMed ID: 21053145
    [Abstract] [Full Text] [Related]

  • 9. Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides.
    Fischer R, Fotin-Mleczek M, Hufnagel H, Brock R.
    Chembiochem; 2005 Dec 28; 6(12):2126-42. PubMed ID: 16254940
    [Abstract] [Full Text] [Related]

  • 10. Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.
    Andaloussi SE, Lehto T, Lundin P, Langel U.
    Methods Mol Biol; 2011 Dec 28; 683():361-73. PubMed ID: 21053143
    [Abstract] [Full Text] [Related]

  • 11. Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides.
    Wolf Y, Pritz S, Abes S, Bienert M, Lebleu B, Oehlke J.
    Biochemistry; 2006 Dec 19; 45(50):14944-54. PubMed ID: 17154532
    [Abstract] [Full Text] [Related]

  • 12. Studying the uptake of cell-penetrating peptides.
    Holm T, Johansson H, Lundberg P, Pooga M, Lindgren M, Langel U.
    Nat Protoc; 2006 Dec 19; 1(2):1001-5. PubMed ID: 17406337
    [Abstract] [Full Text] [Related]

  • 13. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M, Shchepinov M, Sohail M, Benter IF, Hollins AJ, Southern EM, Akhtar S.
    J Control Release; 2004 Sep 14; 99(1):139-55. PubMed ID: 15342187
    [Abstract] [Full Text] [Related]

  • 14. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I, Akita H, Kogure K, Gräslund A, Langel U, Harashima H, Futaki S.
    Acc Chem Res; 2012 Jul 17; 45(7):1132-9. PubMed ID: 22208383
    [Abstract] [Full Text] [Related]

  • 15. Cell-penetrating peptides-based strategies for the delivery of splice redirecting antisense oligonucleotides.
    El Andaloussi S, Said Hassane F, Boisguerin P, Sillard R, Langel U, Lebleu B.
    Methods Mol Biol; 2011 Jul 17; 764():75-89. PubMed ID: 21748634
    [Abstract] [Full Text] [Related]

  • 16. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
    Fonseca SB, Pereira MP, Kelley SO.
    Adv Drug Deliv Rev; 2009 Sep 30; 61(11):953-64. PubMed ID: 19538995
    [Abstract] [Full Text] [Related]

  • 17. Cell-penetrating peptides are excluded from the mitochondrial matrix.
    Ross MF, Murphy MP.
    Biochem Soc Trans; 2004 Dec 30; 32(Pt 6):1072-4. PubMed ID: 15506968
    [Abstract] [Full Text] [Related]

  • 18. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides.
    Nakase I, Takeuchi T, Tanaka G, Futaki S.
    Adv Drug Deliv Rev; 2008 Mar 01; 60(4-5):598-607. PubMed ID: 18045727
    [Abstract] [Full Text] [Related]

  • 19. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS, Hatlevig SA, Hassinger JN, Iversen PL, Moulton HM.
    Bioconjug Chem; 2007 Mar 01; 18(1):50-60. PubMed ID: 17226957
    [Abstract] [Full Text] [Related]

  • 20. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
    Shiraishi T, Nielsen PE.
    Methods Mol Biol; 2011 Mar 01; 751():209-21. PubMed ID: 21674333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.